StocksRunner logo
mail
search
 
menu
 
Novartis AG
$131.34
-0.34%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

NVS Stock Analysis & IQ Rating | Novartis AG

 
 
 

NVS

 

Novartis AG

$131.34

 
-$0.45 | -0.34%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 133.55
 
 
MKT CAP
$ 276.39B
 
52W Low
$ 96.06
 
 
VOL
$ 535.55K
 
P/E Ratio
19.14
 
 
AVG VOL
$ 1.46M
 
RSI
60.35
 
 
TREND
Uptrend
 
 
 

NVS Stock IQ

 
lock  Login to see Novartis AG (NVS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

NVS Target Price

 
 
 

Strengths

 

NVS Rewards

 Earnings are forecast to grow

NVS Rewards

 Outperform the market

NVS Rewards

 Expands stock buyback program

 

Risk Analysis

 

NVS Risk Analysis

 Downgraded on weak valued

 
 

Chart

 
 

$122.23   (+7.45%)

$116.66   (+12.58%)

$116.7   (+12.54%)

$109.38   (+20.08%)

 
 
1year
6month
3month
1month
 

NVS Risk Level

 

NVS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
NVS Risk Level
LOW
HIGH
 

NVS Analysts Opinion

 

NVS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

NVS Earnings Sentiment

 Reported a strong earnings

 
 

Rating

×
 

Rating

 

NVS Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

 

NVS Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

NVS Activity Sentiment

 Expands stock buyback program

 

Future

×
 

Future

 

NVS Future Sentiment

 Earnings are forecast to grow

NVS Future Sentiment

 Outperform the market

 
 

NVS Analysts Opinion

NVS Analysts opinion is negative and it remained unchanged from the past 3 months

 

NVS Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
96%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
100%
90%
 

NVS Street Opinion 

NVS Street view is extremely bullish and have positive views on the near-term outlook

 

NVS Performance Sentiment

 
Sentiments overview associated with NVS events and the stock performance.
 
96%
4%
Positive
Negative
23 out of 24
events present
1 out of 24
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$131.43
 
Resistance
Price
 
$122.23
 
 
Current Price Range
 
$132.39
 
 
Show methods +
 
 

NVS Earnings

 

The TTM reflects 12-month period, providing review of NVS financial performance.

 
Millions of Dollars
TTM
2024
2023
CAGR
 

 
Total Revenue
55,186
51,722
46,660
+8.75%
 
 
Cost of Revenue
13,107
12,827
12,472
+2.51%
 
 
Gross Profit
42,079
38,895
34,188
+10.94%
 
 
Operating Exp
25,395
24,351
24,419
+1.98%
 
 
Operating Inc
16,684
14,544
9,769
+30.68%
 
 
Net Interest Inc
-883
-686
-419
-
 
 
Interest Exp
1,098
1,006
855
+13.32%
 
 
Interest Inc
-
568
627
-
 
 
Other Inc Exp
-193
-218
-227
-
 
 
EPS Growth
6.92
5.92
7.15
-1.62%
 
 

NVS Financial Health

 

The company financial health has moderately improved over the past year

 

Financial Score

 
3.9
 
Next Earnings Date: Oct 28, 2025
 
 
Linked to NVS
IQ
Close Price
Change

 

PFE

4.11

24.85

+0.65%

 

AZN

4.15

83.22

-0.78%

 

MRK

4.07

87.62

+1.54%

 

SNY

3.93

49.66

-0.14%

 

LLY

4.18

799.57

-1.16%

 
 
 
NVS Latest Analysis +
 
 
FAQ About NVS Stock Insights
 

What is NVS current stock price?

What are NVS stock strengths?

What risks are associated with NVS stock?

When is NVS next earnings report?

What is NVS market cap and volume?

What is NVS's current Stock IQ?

Should I buy NVS stock right now?

Is NVS a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVS?

What does a 'Strong Sell' rating mean for NVS?

What factors influence NVS's Stock IQ?

 
 
StocksRunner

Explore our NVS Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored NVS Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our NVS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

NVS

 

Novartis AG

 
 

Current Price

 

$131.34

 
-$0.45 | -0.34%
 
 
52W High
$ 133.55
 
 
MKT CAP
$ 276.39B
 
52W Low
$ 96.06
 
 
VOL
$ 535.55K
 
P/E Ratio
19.14
 
 
AVG VOL
$ 1.46M
 
RSI
60.35
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

NVS Rewards

 Earnings are forecast to grow

NVS Rewards

 Outperform the market

NVS Rewards

 Expands stock buyback program

 

Risk Analysis

 

NVS Risk Analysis

 Downgraded on weak valued

 
 
 
 
 

NVS Stock IQ

 
lock  Login to unlock Novartis AG (NVS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$122.23   (+7.45%)

$116.66   (+12.58%)

$116.7   (+12.54%)

$109.38   (+20.08%)

 
 
1year
6month
3month
1month
 

NVS Analysts Opinion

 

NVS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

NVS Earnings Sentiment

 Reported a strong earnings

 
 

Rating

×
 

Rating

 

NVS Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

 

NVS Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 

NVS Activity Sentiment

 Expands stock buyback program

 

Future

×
 

Future

 

NVS Future Sentiment

 Earnings are forecast to grow

NVS Future Sentiment

 Outperform the market

 
 

NVS Analysts Opinion

NVS Analysts opinion is negative and it remained unchanged from the past 3 months

 

NVS Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
96%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
100%
90%
 

NVS Street Opinion 

NVS Street view is extremely bullish and have positive views on the near-term outlook

 

NVS Risk Level

 

NVS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
NVS Risk Level
LOW
HIGH
 
NVS Performance Sentiment
 
Sentiments overview associated with NVS events and the stock performance.
 
96%
4%
Positive
Negative
23 out of 24
events present
1 out of 24
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$131.43
 
Resistance
Price
 
$122.23
 
 
Current Price Range
 
$132.39
 
 
Show methods +
 
 

NVS Earnings

 

The TTM data reflects the most recent 12-month period, providing overview of NVS financial performance.

 
Millions of Dollars
TTM
2024
2023
CAGR
 

 
Total Revenue
55,186
51,722
46,660
+8.75%
 
 
Cost of Revenue
13,107
12,827
12,472
+2.51%
 
 
Gross Profit
42,079
38,895
34,188
+10.94%
 
 
Operating Exp
25,395
24,351
24,419
+1.98%
 
 
Operating Inc
16,684
14,544
9,769
+30.68%
 
 
Net Interest Inc
-883
-686
-419
-
 
 
Interest Exp
1,098
1,006
855
+13.32%
 
 
Interest Inc
-
568
627
-
 
 
Other Inc Exp
-193
-218
-227
-
 
 
EPS Growth
6.92
5.92
7.15
-1.62%
 
 

NVS Financial Health

 

The company financial health has moderately improved over the past year

 

Financial Score

 
3.9
 
Next Earnings Date: Oct 28, 2025
 
 
 
 
 

NVS Latest Analysis

 
 
 

Novartis Cancer Drug Shows Sustained Benefit In Five-Year Breast Cancer Trial. On Friday NVS) shared results from the five-year analysis of the Phase 3 NATALEE .The data demonstrated a sustained benefit at a median of two years after a three-year treatment with Kisqali (median follow-up: 58.4 months).Results showed a 28.4% reduction in risk of recurrence in patients with high-risk stage II and III hormone receptor-positive/human epidermal growth factor receptor 2-negative early ...

 

Fri Oct 17, 2025

$131.43 | +0.50%
 
Potential

Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML. ® (asciminib) for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph CML-CP) in all lines of treatment.12. In the trial Scemblix demonstrated superior major molecular response (MMR) rates when compared against all TKIs (imatinib nilotinib dasatinib and bosutinib) and also when compared against imatinib alone12. Patients treated w

 

Fri Oct 17, 2025

$131.43 | +0.50%
 
Activity
Potential

Novartis reports positive data from late-stage trial for Fabhalta.

 

Thu Oct 16, 2025

$130.77 | +0.58%
 
Activity

Novartis Strengthens Kidney Disease Pipeline With Promising Data. NVS) on Thursday shared final results from the APPLAUSE-IgAN Phase 3 study evaluating Fabhalta (iptacopan) in adults .NVS is in positive territory. IgA nephropathy also known as Berger'.s disease is an autoimmune kidney disease in which clumps of antibodies specifically immunoglobulin A (IgA) accumulate in the kidney'.s filters leading to inflammation and damage.Fabhalta statistically significant clinically meaningful sup

 

Thu Oct 16, 2025

$130.77 | +0.58%
 
Activity

NVS Reports Positive Late-Stage Data on Kidney Disease Drug . Novartis Fabhalta shows strong phase III results in slowing IgA nephropathy progression paving the way for full FDA approval in 2026.

 

Thu Oct 16, 2025

$130.77 | +0.58%
 
Activity
Earnings

Novartis Receives FDA Approval for Rhapsido (remibrutinib) for Chronic Spontaneous Urticaria. Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30 Novartis announced the US FDA approval of its drug Rhapsido (remibrutinib). This oral pill is approved for use in adult patients with chronic spontaneous urticaria/CSU whose symptoms persist despite treatment with H1 antihistamines. Rhapsido is a pill taken twice daily [….]

 

Mon Oct 13, 2025

$129.12 | -0.70%
 
Activity
Potential

Akero: Novartis Acquisition Puts Focus On Unprecedented MASH Data With EFX.

 

Fri Oct 10, 2025

$130.03 | -0.81%
 
Activity

The Zacks Analyst Blog Highlights SAP Novartis Philip Morris International ImmuCell and ClearOne. SAPs cloud and AI push Novartis strong drug lineup and Philip Morris smoke-free growth headline Zacks latest analyst picks.

 

Thu Oct 9, 2025

$131.06 | -0.97%
 
Potential

Top Stock Reports for SAP Novartis & Philip Morris. SAP Novartis and Philip Morris headline todays top Zacks reports each showing strong momentum and strategic growth drivers despite industry headwinds.

 

Wed Oct 8, 2025

$132.31 | +0.58%
 
Potential

Heres Why Novartis (NVS) is a Strong Value Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

 

Wed Oct 8, 2025

$132.31 | +0.58%
 
Potential

 
 
 
 
 
StocksRunner

Discover NVS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVS. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our NVS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVS Stock trends

NVS Stock performance

NVS Stock analysis

NVS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

NVS Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVS

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVS

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.